JP2024511165A5 - - Google Patents
Info
- Publication number
- JP2024511165A5 JP2024511165A5 JP2023558774A JP2023558774A JP2024511165A5 JP 2024511165 A5 JP2024511165 A5 JP 2024511165A5 JP 2023558774 A JP2023558774 A JP 2023558774A JP 2023558774 A JP2023558774 A JP 2023558774A JP 2024511165 A5 JP2024511165 A5 JP 2024511165A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound
- vancomycin
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163166597P | 2021-03-26 | 2021-03-26 | |
| US63/166,597 | 2021-03-26 | ||
| PCT/US2022/021922 WO2022204499A1 (en) | 2021-03-26 | 2022-03-25 | Rifamycin analogs in combination with vancomycin and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511165A JP2024511165A (ja) | 2024-03-12 |
| JP2024511165A5 true JP2024511165A5 (https=) | 2025-02-25 |
Family
ID=81308077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023558774A Pending JP2024511165A (ja) | 2021-03-26 | 2022-03-25 | バンコマイシンと組み合わせたリファマイシン類似体およびその使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20240189319A1 (https=) |
| EP (1) | EP4313060B1 (https=) |
| JP (1) | JP2024511165A (https=) |
| KR (1) | KR20230162654A (https=) |
| CN (1) | CN117098540A (https=) |
| AU (1) | AU2022246161A1 (https=) |
| BR (1) | BR112023019720A2 (https=) |
| CA (1) | CA3213382A1 (https=) |
| CL (1) | CL2023002840A1 (https=) |
| CO (1) | CO2023013406A2 (https=) |
| ES (1) | ES3017798T3 (https=) |
| IL (1) | IL307220A (https=) |
| MX (1) | MX2023011328A (https=) |
| WO (1) | WO2022204499A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024221162A1 (zh) * | 2023-04-24 | 2024-10-31 | 丹诺医药(苏州）有限公司 | 化合物预防关节假体周围感染的方法 |
| KR20260012505A (ko) | 2024-07-18 | 2026-01-27 | 이화여자대학교 산학협력단 | 기계 학습을 이용한 반코마이신 초회 투여량 적합성 판단 시스템 및 방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118955710A (zh) * | 2018-05-09 | 2024-11-15 | 里珍纳龙药品有限公司 | 抗msr1抗体及其使用方法 |
| PH12021551476A1 (en) * | 2018-12-21 | 2022-04-25 | Regeneron Pharma | Rifamycin analogs and antibody-drug conjugates thereof |
-
2022
- 2022-03-25 ES ES22716719T patent/ES3017798T3/es active Active
- 2022-03-25 AU AU2022246161A patent/AU2022246161A1/en not_active Abandoned
- 2022-03-25 IL IL307220A patent/IL307220A/en unknown
- 2022-03-25 BR BR112023019720A patent/BR112023019720A2/pt unknown
- 2022-03-25 MX MX2023011328A patent/MX2023011328A/es unknown
- 2022-03-25 KR KR1020237036447A patent/KR20230162654A/ko active Pending
- 2022-03-25 US US18/552,303 patent/US20240189319A1/en active Pending
- 2022-03-25 CA CA3213382A patent/CA3213382A1/en active Pending
- 2022-03-25 EP EP22716719.4A patent/EP4313060B1/en active Active
- 2022-03-25 CN CN202280025168.0A patent/CN117098540A/zh active Pending
- 2022-03-25 JP JP2023558774A patent/JP2024511165A/ja active Pending
- 2022-03-25 WO PCT/US2022/021922 patent/WO2022204499A1/en not_active Ceased
-
2023
- 2023-09-25 CL CL2023002840A patent/CL2023002840A1/es unknown
- 2023-10-09 CO CONC2023/0013406A patent/CO2023013406A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2010140682A (ru) | Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство | |
| JP2024511165A5 (https=) | ||
| JPH0692850A (ja) | 胃腸障害治療薬 | |
| JPH08505868A (ja) | クラブラン酸のみまたは他のベータ−ラクタム抗生物質と混合されたクラブラン酸からなる薬剤処方 | |
| Vesely et al. | Rifampin, a useful drug for nonmycobacterial infections | |
| US4749568A (en) | Rubradirin treatment of methicillin-resistant staph | |
| JP5276653B2 (ja) | カルバペネム類を含む殺菌性抗ｍｒｓａ活性医薬組成物 | |
| JPH05271096A (ja) | 抗菌性組成物及びそれを有効成分とする薬剤 | |
| JP2024009968A5 (https=) | ||
| GRAY | The choice of antibiotic for treating infective endocarditis | |
| JP2015536949A5 (https=) | ||
| Alghasham et al. | Trovafloxacin: a new fluoroquinolone | |
| Williams et al. | Bacterial meningitis: current controversies in approaches to treatment | |
| MacGowan et al. | Sequential antimicrobial therapy: pharmacokinetic and pharmacodynamic considerations in sequential therapy | |
| EP1604660A1 (en) | Medicinal composition for treating infection with drug-resistant staphylococcus aureus | |
| KR20140117523A (ko) | 아목시실린 및 클라불란산 칼륨의 소아용 경구 현탁 제형 및 이를 사용하기 위한 방법 | |
| Ball et al. | The natural penicillins—Benzylpenicillin (penicillin G) and phenoxymethylpenicillin (penicillin V) | |
| JP7811652B2 (ja) | リボース及びアミノ酸を含む医薬組成物 | |
| RU2162690C1 (ru) | Препарат для лечения бактериальных инфекций животных и птиц, осложненных микоплазмозом | |
| CN107847501A (zh) | 抗菌组合物以及方法 | |
| Wong | Cefpodoxime proxetil (Vantin®) | |
| JPH01180825A (ja) | 感染症用剤 | |
| Rubinstein et al. | Once‐A‐Day Beta‐Lactam Antibiotic Administration | |
| WO1999052530A1 (fr) | Agents antibacteriens | |
| JP2003146906A (ja) | グラム陽性菌感染症の予防または治療のための併用療法剤 |